Legend Biotech Current Assets

As of the most recent data (June 2026), LEGN shows a current assets of $1.2B. That compares with $1.2B in the prior-year period — down 1.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, LEGN's current assets is now $1.2B (was $1.2B) — a 1.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Legend Biotech is outperforming or lagging.

Tracking LEGN's current assets over time shows whether Legend Biotech is scaling, shrinking, or reshaping that part of the business. The current reading is $1.2B That compares with $1.2B in the prior-year period — down 1.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Legend Biotech's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $1.2B) with ownership activity and broader fundamentals.

Legend Biotech's current assets is $1.2B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.